NCT00036075View on ClinicalTrials.gov

Study Using CP-461 to Treat Advanced Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 31, 2001

Study Completion Date

December 31, 2005

Conditions
Prostate Cancer
Interventions
DRUG

CP-461

Trial Locations (2)

10032

Columbia Presbyterian Medical Center, New York

Unknown

University of Washington, Seattle

Sponsors
All Listed Sponsors
collaborator

Cell Pathways

INDUSTRY

collaborator

OSI Pharmaceuticals

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY

NCT00036075 - Study Using CP-461 to Treat Advanced Prostate Cancer | Biotech Hunter | Biotech Hunter